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Abstract
Fourteen compounds were isolated from acetone extracts of three species of 
seaweeds (Eucheuma serra, a red seaweed, Halimeda opuntia, a green seaweed, 
and Hydroclathrus clathratus, a brown seaweed) using bioautographic TLC methods 
and identified using GC-MS. From Eucheuma serra were isolated 8 compounds 
(3 fatty acids, 3 steroids, and 2 aldehyds). Only two compounds of fatty acid came 
from Halimeda opuntia, whereas Hydroclathrus clathratus produced 6 compounds (4 
fatty acids, one compound each of steroid and ether). All isolated single compounds 
were tested for their antibacterial activities by the agar diffusion method against the 
Gram-positive bacteria Staphylococcus aureus, Bacillus subtilis and Streptococcus 
faecalis, and the Gram-negative bacteria Echerichia coli, Pseudomonas aeruginosa 
and Salmonella typhimurium. All 14 compounds showed activity against Gram-positive 
bacteria, especially Bacillus subtilis, and only 2 compounds showed activity against 
Gram-negative bacteria Escherichia coli. Nine compounds showed activity against 
Staphylococcus aureus, and 4 compounds showed activity against Streptococcus 
faecalis. All compounds were not active against Pseudomonas aeruginosa and 
Salmonella typhimurium bacteria. This study indicated that there is indeed a diversity 
both in kinds and in molecular structures of the antibacterial substances.
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1. INTRODUCTION
Marine organisms including seaweed 
are important sources of biologically active 
compounds. Therefore, it is important 
to examine the pharmacological and 
antimicrobial potentials of metabolite 
compounds derived from seaweed 1,2,3). 
Chemical investigations on seaweeds have 
proven that these organisms produce a 
wide variety of structurally unique secondary 
metabolite compounds. Some of them have 
been shown to possess biological activity 
of potential medicinal value 1,4,5,6,7,8). From 
the Laurencia obtusa, Kurosawa and his 
group isolated two new cyclic polyethers 
with a squalene skeleton, and one of them 
is teurilene while the other is thyrsiferyl 
23-acetate was remarkably cytotoxic against 
P388 cells 9). Bhakuni & Silva 10) and Aubert 
et al. 11), listed a number of the brominated 
isolated compounds from Laurencia spp. 
with quite toxic properties, such as laurencin, 
laureatin, and laurenterol. From numerous 
Caribbean and Pacific species of Halimeda 
were isolated the highly bioactive diterpenoid 
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of halimedatrial 12,13). Acyclic and monocyclic 
sesquiterpenes and linear diterpenoids were 
isolated from Caulerpa spp., also some 
sesquiterpenes derived from Laurencia 
spp. of red seaweed was shown a moderate 
cytotoxic properties 14).
A total of 18 derivatives of O,O-dialkylthio- 
and O,O-dialkylthiophosphoric acids were tested 
for antimicrobial activity using Staphylococcus 
aureus, Bacillus subtilis, Escherichia coli and 
Candida albicans; the acivity was found to 
depend on the length of the alkyl subtituent and/
or the cation size; all derivatives were ineffective 
against E. coli and C. albicans 15). Some fatty 
acid compounds isolated from several species 
of red, green, and brown seaweeds were shown 
to have antibacterial activity 16,17,18,19,20,21,22). In a 
preliminary study, all crude extracts of 21 
species of seaweeds collected from Warambadi 
seashore of Sumba Island were tested against 
Gram-positive and Gram-negative bacteria. 
Acetone and methanol extracts of Eucheuma 
serra and acetone extract of Halimeda opuntia 
showed activities against Bacillus subtilis, 
Staphylococcus aureus, Escherichia coli, and 
Pseudomonas aeruginosa. N-hexane extracts 
of Halimeda opuntia were positive against 
Bacillus subtilis, Staphylococcus aureus, 
and Escherichia coli. Acetone and methanol 
extracts of Hydroclathrus clathratus also 
indicated activities against Bacillus subtilis, 
Staphylococcus aureus, and Escherichia 
coli 23). In a further study, acetone extracts 
of Eucheuma serra, Halimeda opuntia, and 
Hydroclathrus clathratus, were fractionated, 
then isolated by Column Chromatography and 
Thin Layer Chromatography (TLC) 24,25,26,27 and 
the compound isolated were identified by Gas 
Chromatography-Mass Spectrometry (GC-
MS) 28,29). These compounds belong to fatty 
acids, steroids, alkaloids, amine, aldehyde, 
hydrocarbons, and alcohols groups 30). Since 
it is of interest to see the bioactivities of these 
isolated single compounds, they were tested 
against Gram-positive and Gram-negative 
bacteria using the bioautographic TLC assay.
2. MATERIAL AND METHOD
2.1. Material
2.1.1. The fraction samples
The fractions used were ES 1.2, ES 
1.2.1, ES 1.2.2, ES 1.6, ES 1.7, ES 1.8, and 
ES 1.11 from Eucheuma serra,  HO 2.1.2, HO 
2.2, HO 2.3.2, and HO 4.1 from Halimeda 
opuntia, and HC 1.4, HC 2.2, HC 3.1, HC 3.2, 
and HC 3.3  from Hydroclathrus clathratus.
2.1.2. Bacteria for antibacterial  testing
The bacteria used for antibacterial 
activities testing were the Gram-positive 
bacteria Staphylococcus aureus ATCC 
25923, Bacillus subtilis ATCC 6633, and 
Streptococcus faecalis ATCC 29212, 
whereas the Gram-negative bacteria were 
Escherichia coli ATCC 25922, Pseudomonas 
aeruginosa ATCC 27853, and Salmonella 
typhimurium ATCC 14028. 
2.1.3. Chemicals and media
The solvents and media used were 
dichloromethane (Merck), acetone (Merck), 
methanol (Merck), ethanol (Merck), 
ether (Merck), nutrient agar (OXOID), 
Mueller Hinton Agar (OXOID), McFarland 
suspension, paper discs Ø 6 mm (Schleicher 
& Schuell), standard Penicillin-G 10 unit 
(OXOID), Streptomycin 10 µg (OXOID) 
discs, silica gel plates Si-60 F265 (Merck No. 
0554), and sephadex LH-20 (Sigma).
2.1.4. Apparatus
Vacuum rotary evaporator (Buchii 
RE-111), laminar airflow, vortex mixer, 
oven (Memmert-WG), analytical balance 
(Metler), micro pipettes (Socorex), GC-MS 
(GC Hewlett Packard, HP 6890 Series, 
Mass selective detector MSD 5972), GC-MS 
(Shimadzu QP 5050A type).
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2.2. Method
2.2.1. Preparation of samples
The TLC was carried out using TLC 
plate silica gel Si-60 F265 (Merck 0554). 
Standard chromatograms were prepared 
by applying fractions to a silica gel TLC 
plate and developing it with ether: methanol 
(75:25; v/v) under saturated conditions 
24,25,26,27). According to the procedures of the 
bioautographic TLC assay, the developed 
TLC plates were placed directly on the 
agar surfaces and incubated at 350C for 
18 hours. After incubation, plates were 
taken, the spots which affected the bacterial 
growth were chosen and the Retention 
factor (Rf) were measured 27,31). The same 
fractions which indicated to have effect to 
the bacterial growth were passed through 
TLC with the same method. The spots 
with the same Rf and affected the bacteria 
were taken off carefully scrapped from the 
plates and diluted by acetone. Column 
chromatography was carried out using a 
Pharmacia column (Ø 3 cm x 50 cm). To 
purify the compound solution, the column 
was filled with the adsorbent Sephadex LH-
20 and then developed with acetone. The 
fractions were then collected and dried to be 
used for the antibacterial testing and GC-MS 
analysis 27,28,29,32,33.
2.2.2. Preparation of bacterial suspension
All bacteria were inoculated on nutrient 
agar slants and incubated at 350C for 18 
hours. Five ml of sterilized distillated water 
was added and the bacterial culture was 
scrapped with an inoculating needle. The 
bacterial suspension was poured into a sterile 
test tube and homogenized using a Vortex 
mixer. The McFarland standard was used for 
turbidity testing. The bacterial suspension 
was diluted to obtain a concentration of (5 - 
7) x 106 cells per ml.
2.2.3. Evaluation of antibacterial activity 
by agar diffusion
All compounds were tested in vitro using 
paper discs of 6 mm in Ø each containing 50 
µg of the extract. The paper discs containing 
Penicillin-G and Streptomysin (10 µg 
concentration of each) were used as positive 
control while the paper discs containing 
dichloromethane, methanol, and acetone as 
negative control.
The amount of 0.5 ml of the bacterial 
suspension was poured onto the Mueller-
Hinton Agar surfaces on Petri dishes, and 
spread out. The paper discs containing each 
compound were placed on the agar surfaces 
and incubated at 350C for 18 hours. After 
incubation, the diameter of the clear inhibition 
zones were measured 34,35,36).
3. RESULT
The results of bioautographic TLC 
assay showed that there were 16 spots 
affected the bacterial growth (Figure 1.). The 
Rf were (0.07), (0.12), (0.2), (0.25), (0.28), 
(0.32), (0.38), (0.45), (0.50), (0.55), (0.60), 
(0.67), (0.73), (0.78). Three spots had the 
same Rf (0.50). So that there were 14 spots 
which were processed further.
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Figure 1. Result of the Bioautographic TLC 
Assay
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The results of the antibacterial testing 
and compound identification were shown in 
Table 1., and the list of active compounds 
per species shown in Table 2. The 14 
identified compounds active against bacteria 
were:(1) methyl trans-8-octadecenoate or 
8-octadecenoic acid, methyl ester (E); (2) 
3-hydroxy-nonadeca-5,8,11,14-tetraenoic 
acid;  (3) 3-hydroxy-20-methyl heneicosa-
5,8,11-trienoic acid;  (4) dioctyl phthalate 
or 1,2- benzene dicarboxylic acid, dioctyl 
ester; (5) isodecyl octyl phthalate or1,2- 
benzene dicarboxylic acid, isodecyl octyl 
ester; (6) methyl arachidonate or arachidonic 
acid methyl ester; (7) methyl eicosa-
5,8,11,14,17-pentaenoate; (8) androstan-
3-one, 17-(acetyloxy)-, (5α, 17β) or 
dihydrotestosteron acetic acid; (9) androstan-
11-one, 3-(acetyloxy)-17-iodo-, (17α) or 
3-acetoxy-17α -iodo-androstan-11-one; (10) 
pregn-15-en-20-one, 17-methyl-, (5α-17.xi.); 
(11) cholest-5-en-3β-ol, 24-propylidene; (12) 
9-[3-(1-hydroxy-butyl)-oxiranyl]-nonanal; (13) 
11-[3-(1-hydroxy-butyl)-oxiranyl]-undecanal; 
(14) 3,7,11-trimethyl-1-(3-methyl-butoxy)-
dodec-2-en (Figure 2. up to 15.).
 
Figure 2. Compound (1), Methyl trans-8-
octadecenoate or 8-Octadecenoic 
acid, methyl ester, (E)
 
Figure 3. Compound (2), 3-hydroxy-
nonadeca-5,8,11,14-tetraenoic 
acid
 
Figure 4. Compound (3), 3-hydroxy-20-
methyl heneicosa-5,8,11-trienoic 
Acid
 
Figure 5. Compound (4), Dioctyl phthalate or
 1,2- Benzenedicarboxylic acid, 
dioctyl ester
 
F igure 6.  Compound (5) ,  Isodecy l 
oc t y l  ph tha la te  o r  1 ,2 - 
Benzenedicarboxylic acid, 
isodecyl octyl ester
 
Figure 7. Compound (6), Methyl arachidonate 
or Arachidonic acid methyl ester
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Figure 8. Compound (7), Methyl eicosa-
5,8,11,14,17-pentaenoate
 
Figure 9.  Compound (8), Androstan-3-one, 
17-(acetyloxy)-, (5α, 17β) or 
Dihydrotestosteron acetic acid
 
Figure 10. Compound (9), Androstan-11-one, 
3-(acetyloxy)-17-iodo-, (17) or 
3-Acetoxy-17a-iodo-androstan-
11-one
 
Figure 11. Compound (10), Pregn-15-en-20-
one, 17-methyl
 
Figure 12. Compound (11), Cholest-5-en-3β-
ol, 24-propylidene
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Figure 13. Compound (12), 9-[3-(1-hydroxy-
butyl)-oxiranyl]-nonanal
 
Figure 14. Compound (13), 11-[3-(1-hydroxy-
butyl)-oxiranyl]-undecanal
 
Figure 15. Compund (14), 3,7,11-trimethyl-
1-(3-methyl-butoxy)-dodec-2-en
The compounds (1) up to (7) are of the 
fatty acid group, compounds (8) up to (11) 
are of the steroid group, compounds (12) 
and (13) are of the aldehyde group, and 
compound (14) of the ether group. All of 
the 14 compounds showed activity against 
Gram-positive bacteria, especially Bacillus 
subtilis (100% of the identified compounds). 
Only 2 out of 14 compounds (14,3 %) were 
active against Gram-negative bacteria of 
Escherichia coli. All compounds were not 
active against Pseudomonas aeruginosa and 
Salmonella typhimurium. Nine out of the 14 
compounds  (64.3 %) were active against 
Staphylococcus aureus, and 4 out of the 14 
compounds (28.6 %) were active against 
Streptococcus faecalis.
The 8 identified compounds from 
Eucheuma serra which were active against 
O
O
OH
O
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bacteria are 3 fatty acids, 3 steroids, and 
2 aldehydes. Only two compounds, all 
fatty acids, from Halimeda opuntia were 
active against bacteria. Six compunds 
from Hydroclathrus clathratus which were 
active against bacteria are 4 fatty acids, 
one compound a steroid and another one 
an ether.
4. DISCUSSION
The performance of antibacterial 
activities as indicated by inhibition zone in 
this study was substantially lower than the 
data reported in a previous study which 
used whole extracts. These seem to indicate 
that a synergism effect occurred between 
compounds in the whole extract sample 
compared to the single compound. 
Most of the identified compounds 
showed an inhibition activity against both 
Gram-positive as well as Gram-negative 
bacteria. Almost all identified compounds had 
a greater effect against the Gram-positive 
bacteria Bacillus subtilis and Staphylococcus 
aureus (Table 1.). It is important to distinguish 
between the agents which are active against 
Gram-positive bacteria only and those which 
are also active against Gram-negative 
bacteria. Generally, many compounds have 
antibacterial capability against Gram-positive 
bacteria, but lesser number was capable 
of attacking Gram-negative bacteria 37). 
The Gram-negative bacteria have outer 
membrane which protected bacteria cells 
from toxic agents 34,38). The outer membrane 
and the quite narrow of porin channels in 
the membrane have added protection to the 
Gram-negative bacteria. For this reason, 
the diffusion of water-soluble antibacterial 
agents larger than 700 Daltons through the 
outer membrane of Gram-negative bacteria 
is severely limited 34,37,38,39). Furthermore, the 
lipid bi-layer region of the Gram-negative 
bacteria’s outer membrane usually has a 
low permeability toward lipophilic molecules. 
Consequently, the larger and more lipophilic 
antibiotics tend to have significant activity 
against Gram-positive bacteria only 37,40).
There were seven identified compounds 
of fatty acid group and four compounds of 
steroid group were active against bacteria, 
as well as two other compounds of the 
aldehyde group and one compound of ether 
also showed active against bacteria (Table 
1.). The fatty acids, e.g. oleic acid and 
arachidonic acid (eicosatetra-5,8,11,14-
enoic acid) are also found in cell membranes, 
but in addition they act as precursors of 
biologically active metabolites, for example, 
oleic acid is the biosynthetic precursor 
of polyacetylenes like ceprenynic acid 
41). Arachidonic acid is the biosynthetic 
precursor of a large family of metabolites 
known as eicosanoids, which include the 
pharmacologically important prostaglandins 
and leukotrienes 41). The biosynthesis of fatty 
acids is under the control of enzyme called 
fatty acid synthases, and the main building 
block of fatty acid biosynthesis is acetate in 
the form of acetyl-SCoenzyme-A or acetyl-
SCoA 42). Acetyl-Scoenzyme A is also the 
main building block of the terpenoids and 
steroids. All organisms contain a discrete cell 
nucleus (eukaryotes) synthesize steroids, 
or have the capacity to affect a cyclization 
of squalene to form steroid-like molecules, 
or have an absolute requirement for them 
in their diet. Other steroids are metabolized 
to produce biologically active molecules 
like the human hormones and vitamins 
D 41,43). Some marine invertebrates share 
fatty acid profiles which are unique in their 
process of biosynthesizing high amount of 
polyunsaturated fatty acids with a variety 
number and position of unsaturated group. 
Some of marine fatty acids, such as (5Z,9Z)-
14-methyl-5,9-pentadecadienoic acid, are 
antibacterial against Gram-positive bacteria 
Streptococcus and Staphylococcus 44). 
More active compounds were found in 
Eucheuma serra if compared to Halimeda 
opuntia and Hydroclathrus clathratus. Two 
interesting active compounds found in this 
study are worth noting. There are methyl 
trans-8-octadecenoate or 8-Octadecenoic 
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acid, methyl ester (E) (1), a fatty acid in trans 
formation from Hydroclathrus clathratus, and 
androstan-11-one, 3-(acetyloxy)-17-iodo-, 
(17α) or 3-Acetoxy-17α -iodo-androstan-
11-one (9), a steroid containing iodium from 
Eucheuma serra. Both compounds were 
active against Gram-positive (Staphylococcus 
aureus, Bacillus subtilis, and Streptococcus 
faecalis) and Gram-negative bacteria 
(Escherichia coli), especially the compound 
(9) was active against all the Gram-positive 
bacteria (Table 1.).
Robles et al. ,45) suggested that 
antibiosis in algae is extremely complex and 
involves numerous different activities which 
manifest themselves differently with respect 
to habitat, season and life history stages. It 
means that the difference in quantities and 
qualities of seaweed’s active secondary 
metabolite products were synthesized 
under different conditions, such as seasons, 
geographic location, habitat factors and 
genetics which affect the spectrum of 
biologically active secondary metabolites 
produced. The different results indicated the 
possibility that genera, species, and their 
physiological state or life stages, affected 
the capability of the seaweed to synthesize 
different quantities and qualities of bioactive 
secondary metabolites  .
The active compounds were presented 
in Table 2., displayed fatty acid, steroid, 
aldehyde, and ether groups, respectively. The 
antibacterial compounds of fatty acids are 
unsaturated groups. Based on the molecular 
structures of active compound, it could be 
suggested that the number and position of 
unsaturated in fatty acids are the key of its 
antibacterial activity. As in 3-hydroxy-20-
methyl heneicosa-5,8,11-trienoic acid (Figure 
4.) which has three double bond showed more 
active than its analog of 3-hydroxy-20 methyl 
heneicosa-5,8-dienoic acid. Moreover, the 
number of unsaturated was also supposed 
as the factor of the activity of methyl eicosa-
5,8,11,4,17-pentaenoate (Figure 8.). Active 
compound was also showed by phtalate 
derivates such as dioctyl phtalate (Figure 
5.) and isodecyl octyl phtalate (Figure 6.). 
But the other phtalate derivates, namely, 
1,2-benzendicar-boxylic acid, bis (2-ethylexyl) 
ester was not active, because of the presence 
of 2 ethyl substituents which caused steric 
hindrance at carbonyl ester groups.
The active compounds of aldehyde 
group were also obtained. The activity factor 
of this group may be caused by the presence 
of epoxy group as in 9-[3-(1-hydroxy-butyl)-
oxiranyl]-nonanal and 11-[3-(1-hydroxy-
butyl)-oxiranyl]-undecanal respectively 
(Figure 13. & 14.). The other active 
compounds were steroid and ether groups. 
The activity of steroids could be caused by 
ketone group in the steroid ring and side 
chain of acetyloxy group, as well as the 
presence of halogen (iodine) substituent. 
Moreover, the ether compound was also 
active as showed by 3,7,11-trimethyl-1-(3-
methyl-butoxy)-dodec-2-en (Figure 15.).
 
5. CONCLUSION
The results of this study indicated that three 
seaweed species (Eucheuma serra, Halimeda 
opuntia, and Hydroclathrus clathratus) which 
were collected from Warambadi seashore of 
Sumba Island, showed a significant capacity 
to produce a variety of compounds with 
antibacterial activities.
The 14 compounds with an active 
antibacterial activity, consisted of 8 
compounds from Eucheuma serra (3 fatty 
acids, 3 steroids, 2 aldehyds), two fatty acids 
compounds from Halimeda opuntia, and six 
compounds from Hydroclathrus clathratus 
(4 fatty acids, and one compound each of 
the steroid and ether group). All compounds 
were active against Gram-positive bacteria 
especially Bacillus subtilis and only 2 
compounds showed active against the Gram-
negative Escherichia coli. All compounds 
were not active against Pseudomonas 
aeruginosa and Salmonella typhimurium.
In term of antibacterial activity, two 
interested active compounds are methyl 
trans-8-octadecenoate or 8-octadecenoic 
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acid, methyl ester (E) (a fatty acid in trans 
formation from Hydroclathrus clathratus), and 
androstan-11-one, 3-(acetyloxy)-17-iodo-, 
(17α) or 3-acetoxy-17α -iodo-androstan-
11-one (a steroid contain iodium from 
Eucheuma serra), both of compounds were 
active against Gram-positive and Gram-
negative bacteria.
The molecular structures produced 
showed that the fatty acids active compounds 
are of the unsaturated group. It is likely that 
the number and position of unsaturated 
in fatty acids are important factors of its 
antibacterial activity. Two of four compounds 
of aldehydes were active substances, and 
in this case may be caused by the presence 
of epoxy group in the molecular structures, 
whereas, the active compounds of steroids 
could be caused by the presence of ketone 
group in the steroid ring and acetyloxy group 
in the side of chain, as well as the presence 
of iodine substituent.
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 No Compound S.aureus B.subtilis S.faecalis E.coli P.aeruginosa S.typhimurium
Fatty Acids
1
Methyl trans-8-
octadecenoate or 
8-Octadecenoic acid, 
methyl ester, (E)
6.8 7.4 - 6.5 - -
2
3-Hydroxy-nonadeca-
5,8,11,14-tetraenoic 
acid
6.5 7.0 - - - -
3
3-Hydroxy-20-methyl 
heneicosa-5,8,11-
trienoic acid 
6.8 6.8 - - -
4
Dioctyl phthalate or 1,2- 
Benzenedicarboxylic 
acid, dioctyl ester 
6.7 7.4 - - - -
5
Isodecyl octyl phthalate 
or 1,2- Benzene dicar- 
boxylic acid, isodecyl 
octyl ester
7.0 7.5 6.5 - - -
6
Methyl arachidonate or 
Arachidonic acid methyl 
ester 
6.5 6.8 - - - -
7
Methyl eicosa-
5,8,11,14,17-
pentaenoate 
- 6.5 - - - -
Steroids
8
Androstan-3-one, 
17-(acetyloxy)-, 
(5α, 17β) or 
Dihydrotestosteron 
acetic acid
- 6.6 - - - -
9
Androstan-11-one, 
3-(acetyloxy)-17-iodo-, 
(17α) or 3-Acetoxy-17α 
-iodo-androstan-11-one
7.0 7.8 7.0 6,5 - -
10 Pregn-15-en-20-one, 17-methyl - 6.8 6.5 - - -
11 Cholest-5-en-3β-ol, 24-propylidene 7.0 7.0 - - - -
Aldehydes
12 9-[3-(1-hydroxy-butyl)-oxiranyl]-nonanal - 6.7 - - - -
13 11-[3-(1-hydroxy-butyl)-oxiranyl]-undecanal - 6.7 - - - -
Ether
14
3,7,11-Trimethyl-1-(3-
methyl-butoxy)-dodec-
2-en
6.7 7.0 6.5 - - -
P-10 = Penisllin-G (Conc. 10 
µg) 8.8 8.3 8.0 7.8 - 8.0
S-10 = Streptomycin (Conc. 
10 µg) 18.5 20.5 18.0 2.0 10.5 11.0
C (Acetone) = control - - - - - -
Table 1. Antibacterial activity of identified compounds
Gram-positive bacteria  : Staphylococcus aureus ATCC 25923; Bacillus subtilis ATCC 6633; 
Streptococcus faecalis ATCC 29212;Gram-negative bacteria : Escherichia 
coli ATCC 25922;  Pseudomonas aeruginosa ATCC 27853; Salmonella 
typhimurium ATCC 14028
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No. Compound
Eucheuma serra
Fatty Acids
1 3-Hydroxy-nonadeca-5,8,11,14-tetraenoic acid
2 3-Hydroxy-20-methyl heneicosa-5,8,11-trienoic acid
3 Dioctyl phthalate or 1,2- Benzenedicarboxylic acid, dioctyl ester
Steroids
4 Androstan-3-one, 17-(acetyloxy)-, (5α, 17β) or Dihydrotestosteron acetic acid
5 Androstan-11-one, 3-(acetyloxy)-17-iodo-,  (17α) or 3-Acetoxy-17α -iodo-
androstan-11-one
6 Pregn-15-en-20-one, 17-methyl
Aldehydes
7 9-[3-(1-hydroxy-butyl)-oxiranyl]-nonanal 
8 11-[3-(1-hydroxy-butyl)-oxiranyl]-undecanal 
Halimeda opuntia
Fatty acids
1 Dioctyl phthalate or 1,2- Benzenedicarboxylic acid, dioctyl ester
2 Isodecyl octyl phthalate or 1,2- Benzene dicar- boxylic acid, isodecyl octyl ester
Hydroclathrus clathratus 
Fatty acids
1 Methyl trans-8-octadecenoate or 8-Octadecenoic acid, methyl ester, (E)
2 Methyl arachidonate or Arachidonic acid methyl ester 
3 Methyl eicosa-5,8,11,14,17-pentaenoate 
4 Dioctyl phthalate or 1,2- Benzenedicarboxylic acid, dioctyl ester 
Steroids
5 Cholest-5-en-3β-ol, 24-propylidene
Ether
6 3,7,11-Trimethyl-1-(3-methyl-butoxy)-dodec-2-en
Table 2. List of the active compounds of Eucheuma serra, Halimeda opuntia,and 
Hydroclathrus clathratus
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